Tokyo, Oct. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059332) titled 'Prospective observational study of ADLs in elderly patients received lung cancer radiotherapy' on Oct. 8.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center
Condition:
Condition - lung cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To prospectively investigate the proportion of patients aged 75 years or older with non-small cell lung cancer who undergo definitive radiotherapy and experience a decline in activities of daily living (ADL) after treatment
Basic objectives2 - Others
Eligibility:
Age-lower limit - 75
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Age 75 years or older at the time of obtaining informed consent
2) Scheduled to undergo definitive radiotherapy for non-small cell lung cancer
3) No concurrent or sequential chemotherapy planned
4) No prior radiotherapy involving the hilum or mediastinum, including for other cancer types
5) Able to communicate in Japanese and has provided written informed consent to participate in the study
Key exclusion criteria - 1) Presence of active double (synchronous) cancer
2) Any other condition judged by the principal investigator to be inappropriate for study participation
Target Size - 100
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 09 Month 12 Day
Date of IRB - 2025 Year 09 Month 26 Day
Anticipated trial start date - 2025 Year 10 Month 08 Day
Last follow-up date - 2029 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067868
Disclaimer: Curated by HT Syndication.
